Dixon, Brian E.
Fadel, William F.
Duszynski, Thomas J.
Caine, Virgina A.
Meyer, Joeseph F.
Saysana, Michele
Article History
Received: 30 June 2022
Accepted: 4 November 2022
First Online: 10 November 2022
Declarations
:
: All methods were performed in accordance with the U.S. Department of Health and Human Services (HHS) regulations for the protection of human subjects in research (45 CFR 46), the Common Rule (45 CFR 46 Subpart A), and the Health Insurance Portability and Accountability Act of 1996 (HIPAA) regulations governing protected health information. The study was approved by the institutional review board (IRB) at Indiana University as protocol 10764 and waived informed consent requirements under the public health exemption.
: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Dr. Dixon reports a grant from IU Health which funded the analysis. Dr. Dixon and Dr. Fadel report a grant from CDC to study COVID-19 vaccine effectiveness. Dr. Dixon and Dr. Fadel report grants from the Indiana State Department of Health to study COVID-19 infection rates and surveillance. Dr. Saysana and Mr. Meyer are employees of IU Health, which was contracted to perform COVID-19 mitigation for the 2021 NCAA Tournament. No other potential conflicts of interest were disclosed.